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Abstract
A multi-focal multi-centric, malignant tumour of vascular origin arising in bone in a 55-year-old man is described. The
presenting symptoms were pain and weight loss. Radiologically, multiple lytic lesions were demonstrated in the long bones
of both legs and throughout the pelvis. Histological examination demonstrated an angiosarcoma which was predominantly
low grade in nature but with focal areas of intermediate grade. Turnout cells expressed the endothelial markers CD31,
CD34 and von Willebrand’s factor. There was rapid radiological progression of disease with no response to radiotherapy.
Pain abated within a few days of institution of doxorubicin, 75 mg m-z, but the patient died of massive pulmonary
thromboembolism 14 days later, 11 months after the first symptoms.
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Introduction
Tumours of vascular origin arising in bone are rare,
comprising fewer than 1% of primary bone
tumours. Difficulties exist in discriminating histo-
logically benign vascular lesions from tumours
which may pursue a more rapid, malignant course.
Furthermore, the clinical course of such tumours
may vary greatly. This has led to considerable con-
fusion in terminology, particularly in the application
of the term haemangioendothelioma to low-grade
malignant vascular lesions and angiosarcoma to
higher grade tumours. Mirra suggested that more
than two-thirds of reported low-grade haemangioen-
dotheliomas or angiosarcomas may in fact be benign
haemangiomatous lesions.2 The term, epithelioid
haemangioendothelioma, introduced by Weiss and
Enzinger for a group of soft tissue tumours of vary-
ing origin,
3 is now also sometimes used for primary
tumours of bone.
4 Such tumours are said to pursue
a relatively indolent course, metastasize rarely, and
are distinguishable clinically and histologically from
angiosarcoma.
4 We are encouraged to report the
following patient because of the absence from the
literature of a similar case and because it may illumi-
nate further some of the areas of difficulty that
surround this fascinating but uncommon group of
tumours.
Patient
In November 1993, a 55-year-old male smoker pre-
sented with a painful right calf. Over the next 8
months, his symptoms persisted and further pain
developed in the right knee and left ankle. After an
initial diagnosis of a muscle tear, he was treated with
physiotherapy and immobilization in plaster. Radio-
graphs of the right femur, tibia and fibula performed
in December 1993 were thought to be normal.
When the pain failed to improve, an arteriogram was
performed which demonstrated occlusion of the
right popliteal artery and he was referred for surgery.
By July 1994, his pain had worsened, left ankle
oedema developed and he had lost weight.
Investigations revealed a microcytic anaemia (Hb
11 g dl-1), erythrocyte sedimentation rate (ESR)
raised at 120 mm h- impaired renal function (serum
creatinine 386 #mol 1-1) and hypercalcaemia (cor-
rected calcium 3.75 mmol 1-1 ). Parathyroid hormone
levels, serum immunoglobulins and prostate specific
antigen levels were normal. Bence Jones proteinuria
was absent. A bone marrow trephine biopsy from the
posterior iliac spine was normal.
A chest radiograph was also normal. Radiographs
of the long bones of both legs showed multiple lytic
lesions of varying size, more on the left than right
(Figs 1 and 2). The tumour involved both femurs,
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Fig. 1. Radiograph of left leg showing
multiple small lytic lesions of varying size
distributed throughout the femur, tibia and
fibula.
Fig. 2. Overlapping lesions with in-
distinct borders indicating histologically
aggressive disease.
Fig. 3. Computed tomogram through right tibia andfibula.
The larger lesion is causing cortical destruction without expansion
on a surrounding soft tissue mass.
Fig. 4. Multiple lesions were visible throughout the pelvis on
computed tomography performed at presentation.
Fig. 5. Histology ofthe angiosarcoma showing well-developed neoplastic blood vessels lined by atypical endothelial cells. Intraluminal
erythrocytes are visible in (a). Piling up ofthe endothelium and apparentshedding ofcells into the lumen is seen in (b) (both haematoxylin
& eosin, 400).Angiosarcoma of bone 185
Fig. 6. Extensive disease throughout the
long bones of both legs, 2 months after
diagnosis.
Fig 7. Radiographs from July 1994 (eft) and September 1994 (right) demonstrate rapid progression of disease.186 E. Kakouri et al.
tibiae and fibulae. Some lesions had clearly defined
margins, others very indistinct edges. There was no
periosteal reaction but cortical destruction was seen.
Some lesions appeared to overlap (Fig. 2). Review
of X-rays taken in December 1993 revealed two
4-mm lytic lesions in the diaphysis of the right tibia.
Similar lesions were also seen throughout the proxi-
mal femora and the pelvic bones, including the
sacrum, on computed tomography (CT) (Figs 3 and
4). There were no adjacent soft tissue abnormalities.
A 5-cm abdominal aortic aneurysm was noted but
no visceral metastases were identified. Bone scan
showed patchy uptake throughout the fibulae, tibiae
and femora. Uptake was particularly intense around
the left ankle and right knee.
Biopsy was performed of a representative lesion in
the left tibia. Multiple tissue fragments were exam-
ined, revealing foci of angiosarcoma (Fig. 5). The
angiosarcoma consisted of clusters of atypical cells
with high nuclear-to-cytoplasmic ratios and, focally,
pronounced nuclear pleomorphism. Tumour cells
formed well-developed vascular channels within
which many erythrocytes were identified (Fig. 5(a)).
Tumour cells were often piled on top of each other
and apparently shed into the lumen (Fig. 5(b))
Immunohistochemistry demonstrated expression of
the endothelial markers CD31, CD34 and yon
Willebrand’s antigen by neoplastic cells. The
endothelial marker, cytokeratin, was not expressed.
The tumour showed some foci of relatively low-
grade histology with few mitoses and relatively little
nuclear pleomorphism. However, in other areas,
there were loci of substantial nuclear pleomorphism
associated with considerable mitotic activity (4 per
10 high power fields) judged to be of intermediate
histological grade.
Hypercalcaemia responded to pamidronate and
renal function improved. In August 1994, pred-
nisolone (10 mg day-1) was started and radiother-
apy (25 Gy) given to both tibiae but without
symptomatic improvement. One week later the
patient developed a confusional state, attributed to
hyperglycaemia secondary to corticosteroids. Insulin
was begun and his mental state improved. Radiolog-
ical progression was evident (Figs 6 and 7). Doxoru-
bicin (75 mg m-2) was given and resolution of pain
was noted within a few days but the patient died
suddenly at home 14 days later, just 11 months
from the first symptoms.
At autopsy, there was macroscopic evidence of
thrombus in the calf veins of both legs, the cause of
death being occlusion of both pulmonary arteries by
thromboemboli. No evidence of visceral metastatic
disease was seen. Tissue was not taken for histologi-
cal examination nor was a more detailed examin-
ation made of calf and sacral venous plexi.
Discussion
Several different terms have been applied to bone
tumours of vascular endothelial origin since Stout
first described haemangioendothelioma in 1943,
and it is now possible to distinguish both clinical
and pathological groupings within this diagnosis.
5
The benign course of many haemangioendothe-
liomas led to an adoption of the terms angiosarcoma
or haemangiosarcoma to distinguish those more
malignant tumours which display very disordered
architecture of the characteristic complex, anasto-
mosing vascular channels and a greater degree of
pleomorphism.
6 Other investigators have suggested
that tumours which follow an extremely benign
course are in fact haemangiomas and that angiosar-
coma should be the term adopted for all malignant
tumours arising from vascular endothelium. 2’7 In
our case, it was possible to demonstrate areas of
varying histological grade even though only a single
lesion was sampled. This feature may be generally
under-recognized because of sampling constraints.
However, variation in histological grade has not
been reported consistently in histological examin-
ation of tumours treated with radical surgery when
larger quantities of tissue are inspected. 6’8
The most distinctive clinical feature of this disease
is the occurrence of multiple bone lesions. These
may be present in just one bone (multi-focal, soli-
tary) or in adjacent bones (multi-focal, multi-cen-
tric, contiguous). The presence of lesions in several
bones separated by more than one joint (multi-focal,
multi-centric, non-contiguous) is exceptional and
individual cases have never been very clearly docu-
mented.2’6’9’1 Although, in this case, lesions were
visible in all bones of both lower limbs, they were
also seen in the pelvis and sacrum, making this a
rather unusual example of contiguous disease.
The distribution of lesions raises questions as to
how this disease spreads. It has been postulated that
spread to contiguous bones may be via metaphyseal
veins, with tumour detectable in both large and
small veins, a process that may occur relatively
slowly.2 Termed angiotropism, both antegrade and
retrograde spread can occur. In this case, it is poss-
ible that retrograde spread, via the pelvic venous
plexus, is the mechanism by which lesions appeared
in both tibiae and fibulae although no pathological
confirmation of venous involvement was made. We
believe that although the distribution of disease
described in this report fits with Mirra’s definition of
contiguity, more supporting evidence for such a
remarkable process of dissemination is needed to
account safely for such widespread involvement and
rapid progression. The predilection of this tumour
for bone remains unexplained.
Extraosseous metastases are occasionally seen late
in the course of patients presenting with solitary
angiosarcomas of bone but have not been described
in multi-focal disease. Two points are worthy of
emphasis with regard to this case: first, there was no
evidence of pulmonary metastases at autopsy;
second, there was evidence of thrombosis in the calfvenous plexus of both legs with death being caused
by pulmonary embolism. It is tempting to speculate
whether these were in fact tumour emboli, as seen in
other primary bone tumours and choriocar-
cinoma. 11-13
Numerous authors have commented that multi-
focal disease pursues a more indolent course and
carries a more favourable prognosis than that associ-
ated with a single lesion, when metastases, most
often to the lungs, may occur with great rap-
idity. 1’14-16 This has been disputed by some who
instead have stressed the prognostic importance of
histological grade as a more useful determinant of
outcome than the number of lesions. 8’9 Although no
high-grade tumour was seen in the biopsy material,
certain clinical features indicate that the tumour was
more aggressive. The progression of disease radio-
logically was rapid over the l 1-month period of
observation. Individual lesions varied in size, clarity
of margin and associated cortical destruction. No
sclerosis or ’soap bubble’ appearance of ballooning
periosteum was evident, both said to predict for a
more indolent course, but neither was there pe-
riosteal reaction or evidence of soft tissue disease,
which are radiological features of higher grade dis-
ease.8’9’17’18 Finally, the patient developed marked
hypercalcaemia, previously reported only once in a
patient with the multi-focal, contiguous variant.1
Management of malignant vascular tumours is
primarily surgical but recurrence after curettage
alone is common. Amputation may still be curative
in patients with recurrent tumours, even if multi-
centric.2’1’19 Campanacci et al. has recommended
that grade I lesions are treated by curettage alone,
grade II lesions by resection sometimes with radio-
therapy, and that Grade III tumours are treated
aggressively with ablative surgery and chemotherapy.
Caution must be applied to the application of such
guidelines as differences in the clinical course clearly
existed within the groups.
8 Radiotherapy has been
widely applied and appears to be effective for local
control in some patients,9’19’2 occasionally with dra-
matic benefit.1’ There are no reports ofthe efficacy
of chemotherapy in the literature although some
authors have recommended its use for angiosar-
coma. 8’9 In this case, there was no symptomatic
response to radiotherapy but there was rapid resol-
ution of pain soon after chemotherapy began.
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